The role of the mammalian target of rapamycin (mTOR) complex in autocrine effects of Sema3A that promote cancer formation [42] and help regulate disposal of senescent cells with DNA damage [39, 43] remains to be explored. This evidence concerns the gene SEMA3A and cancer.